[Interstitial Lung Disease after OK-432 Pleurodesis for Malignant Pleural Effusion in Breast Cancer-A Case Report]

Gan To Kagaku Ryoho. 2023 Feb;50(2):183-186.
[Article in Japanese]

Abstract

The patient was a 42-year-old woman. After 4 courses of capecitabine therapy for right chest wall recurrence of breast cancer, ER(+, 10-15%), PgR(-), HER2(-), she underwent pleurodesis using OK-432 for increased right pleural effusion. On the 12th day after pleurodesis diffuse infiltrative shadows in the right lung, and frosted shadows in both lungs, were observed, and she was diagnosed with drug-induced lung injury. About 3 weeks after administration of prednisolone 1 mg/ kg a tendency for improvement in lung injury was observed, but the patient died of breast cancer progression. Drug- induced lung injury by pleurodesis carries the risk of delaying resumption of chemotherapy. We report this case with a review of the literature.

Publication types

  • Review
  • Case Reports
  • English Abstract

MeSH terms

  • Adult
  • Breast Neoplasms* / drug therapy
  • Female
  • Humans
  • Lung Diseases, Interstitial* / drug therapy
  • Lung Injury*
  • Picibanil / therapeutic use
  • Pleural Effusion* / therapy
  • Pleural Effusion, Malignant* / etiology
  • Pleurodesis / adverse effects

Substances

  • Picibanil